Abstract
BCR-ABL1-like B-acute lymphoblastic leukemia (B-ALL) is a genetically heterogeneous group of high-risk B-ALL that benefits from targeted tyrosine kina......
小提示:本篇文献需要登录阅读全文,点击跳转登录